Just quick summary to bring this to your attention; more detail will hopefully follow.

This stock floated yesterday at 10p and has since doubled. It has, needless to say, suddenly become very popular on another BB.

The company is profitable already and trading on an estimated (by yours truly) forward PE for the current year of 9 at SP 20p. EDIT: Hoodless Brennan estimate EPS for Full Year 2006 will be 2.18p - see article (link below).

Free float is 11.4% of the 81.2 million shares in issue - most are held by the directors.







Extremely useful Investegate article LINK


Extremely useful Hoodless Brennan analysis LINK


PDYOR, etc.

Dr Mike Wyllie, Non-Executive Chief Scientific Officer of Taihua, is also Chief Scientific Officer and founder of Plethora Solutions (PLE).

2.2 million shares traded today out of a free float of 9.25 millionn.

TAIH Bid: 19p Offer: 20p Change: 5.5

Have you bought into these.

I have indeed - got in ASAP on the same logic I applied to SOLA, i.e. that it looks undervalued and is growing fast.

Got in at 20p

st
I just joined you @ 19.9

Hi gents bought in @ 13p Soul isn't the free float 7.2 million shares (720,000/ by 10p).

laurie
Hi laurie here we go again.

Still quiet on GTL but this week has been good will wait and hold on GOO but down a lot at present.
I suggest you have a look at ADA it should continue to climb.
This one I am not sure where it is headed but the fundamentals are good and some of the staff experienced especially the Chief Science Officer.

Copied from Dark Side :
DR Mike Wyllie, a member of the Pfizer team which invented Viagra in the late 1990s, is Chief Scientific Officer at Taihua, which starts trading on Aim today at 10p. Dealers reckon the bio-pharmaceutical company which manufactures anti-cancer agents from Chinese yew trees has a bright future despite stiff competition. It achieved 2005 pretax profits of 1.2m on sales of 2.1m.

laurie
Cheers sit tight on this one and see what happens.

Will watch carefully on Monday and may top splice - have got 20,000 so will see.

Some thing for the W/End

http://www.allipo.com/articles/8518/ipo-taihua-plc-first-day-of-dealing

This will be the next bit of news.

In addition, the Group is currently awaiting approval to distribute into South Korea
and anticipates receiving this approval before the end of 2006.

Laurie, the number of shares in the placing at flotation was 7.2 million. "Free float" refers not to the flotation but to the number of shares not subject to lock-in arrangements, i.e. the number of shares generally expected to be available for trading at any one time, and these shares number around 9.25 mil at present.

Driver, glad to have you aboard. Laurie, you too. You beat us to the bargain - next time, why not write us a quick thread and tell us all about it :o)

More of the same on Monday?

"Tai-hua" - is that any relation to a Chai-hua-hua?

.
.
.

I'll get me coat . . . .

ah, taihua. i'm thinking of going there on me hols next year ........
.
.
.
soul, do you wanna get mine while you're there ....

ST
It's laurie's turn to do a thread I've got to many. (It's a lot of responsibility you know) LOL

No spare money---woe is me!! I'll have to think of something.... thanks ST. Do you expect a pull back ? It looks unlikely to me for a while.

Driver I,ve got about several threads including NFDS but no one uses them though I might start another new one on Kiotech later.

st
It looks like you have got the thread.

Great start up 0.75 already!

Driver, I have the thread. Commander Riker, you have the conn. Or was the conn the thing in the submarine in Crimson Tide?

Where was I? Oh yes, shares!

As Laurie rightly says, it's up! I'll try and take a look at your threads, sometime, too, Laurie!

MP, I am not sure whether to expect a pull-back; I tend to think more in terms of where this might be when the next results are published (possible trading update towards year-end or sometime in Jan?) or in 6/12/18 months.

Good luck to all anyway!

st
Crimson Tide you got it in one.

Driver, that's good news, at least one part of my brain is working this morning, even if it's only the bit that remembers silly trivia! :o)

ST-I'm in couldn't resist any longer!! I have a good feeling about this one so sold some EPY to get in. Here's hoping for a good result for us all.

Welcome aboard, MP. May your investment indeed do you proud!

250,000 sell just gone through @ 20p.

If mps got a tingling sorry a feeling then 100p here we come.

sp is holding up punters shouldn't be selling this will go north when the next bit of news comes in, hopefully before the years out.

In addition, the Group is currently awaiting approval to distribute into South Korea
and anticipates receiving this approval before the end of 2006.

moneyweek is planning a new year article on chinese shares--I'm betting TAIH SOLA and GNG are in it.

oh s.....!!

Well been away since yesterday for 22nd Wedding Anniversary quite impressed that it has held up. Was expecting it to be lower!

laurie
That's good news then youre the only one in profit lol still looking good IMO 25p tomorrow.

Well done Laurie. I have only been married 15 years and mine won't hold up at all. It is now considerably lower. But then again, so is a large amount of the wife.
Alan

A not-particularly exciting RNS: Taihua Plc - Total Voting Rights
RNS Number:2028O
Taihua Plc
19 December 2006

Taihua plc (the 'Company')


Total Voting Rights


For the purposes of the transitional provisions of the Financial Services
Authority's Disclosure and Transparency Rules, the total number of ordinary
shares of 10p each in the capital of the Company in issue as at the date of this
notice is 81,211,000 with each share carrying the right to one vote.


There are no shares held in treasury.


Therefore, the total number of voting rights in the Company is 81,211,000.


The above figure may be used by shareholders in the Company as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the Disclosure and Transparency Rules.

MMs having a funny turn day today any buys or sells they are moving the sp - only three trades so any buys and the sp will come back.

A good report and one of 5 recommended companies from Hoodless Brennan up 1p so looking better.

http://www.hoodlessbrennan.com/products-services/share-tips/?utm_source=tips&utm_medium=email&utm_campaign=tipsdec06

laurie squash
Cheers laurie, reposted link.

Substantial room for profit growth as
range expands to include injectables
and export licences are obtained for
South Korea and EU
Growth in hospital client list for own
brand range of herbal medicines
PE of 6.2x based on 2006 numbersgood
comparison with UK biotech peers
Low cost base- admin expense just 8%admin expense just 8%
of 2005 sales

http://www.hoodlessbrennan.com/products-services/share-tips/?utm_source=tips&utm_medium=email&utm_campaign=tipsdec06

Driver do you want to put the link on the dark side as well.

laurie
Just done it.

EDIT: chart in header replaced with 5-day chart.

Driver, many thanks for yor post of the Hoodies article - a good find!

Taking away the most salient point of the report, TAIH is forecast to make EPS of 2.18p for the year ending 31 Dec 2006. Which, I should not need to remind anybody, is in ten days' time.

Currently we are on a PE of around 8.5 (at closing offer price of 18.5p). So we could well see a lift in the SP as and when a trading update is released, and when the results come through at the end of March.

Looks very good, IMO. Glad I bought and am waiting for great things in the New Year.

IMO, PDYOR, etc.

Laurie, sorry; the credit should go to you in the first instance for the HB article. I have now pasted the link to the header.

Decent recovery today, too: TAIH Bid: 16.5p Offer: 18.5p Change: 1

good luck to all!

sorry to sound pessimistic...but it seems unlikely that TAIH will go far because chinese herbal medicine is not well researched and its potential benefits and side-effects are not known. There aren't any randomised controlled trials on such herbal medicines. Very risky investment.

HL, I believe that Paclitaxel and Homoharringtonine are already used in Western countries.

And the TCM side, already accepted in China, is due to be expanded in China.

Does anyone else have any views?

ST,
Gotta say, I respect your stockpicking and when you started the thread I had a good close look, but I'm gonna go with hlyeo on that.
Chinese medicine does not appear to have gripped the market as one may have thought. Every shopping centre you go in has a Dr & herbs outlet, but never anyone in them! I am afraid that complimentary or alternative treatments will be treated as "faddy" for some years to come and while this may enjoy an opening splash, I see no real long term future as a large organisation. Expansion is very limited.
If these treatments ever become researched and regulated, they may become more mainstream and offer greater expansion potential, but regulation is a double edged sword. it also offers higher costs and massive restrictions on trade.
I wish all the investors the very best of luck, as I would with any share, but it is not for me. I really hope I am proved wrong and spend the rest of my days kicking myself for net getting in with you all.
WTFDIK & DYOR, but I'm sitting it out for the time being.
Alan

ST, this stock was classed as AVOID by Monisha V on allnewissues.com and a buy by Hoodless B, though HB are share holders (2.46%).

Reasons for the Avoid category were:

Company trying to sell a drug which is off patent, therefore margins will be low.
the impact on profitability of the Leukemia drug will take some time and necessary approvals not yet obtained.

Hope that helps.

LOL - it seems this one just isn't all that popular with this BB!

Seriously, thanks to all for explaining your reservations. I have to admit that the low PE is a major factor behind my interest. Will hang on and see what happens at the next results - hopefully it won't be a complete train wreck.

However, I must say that I think there are positives amongst the negatives as well and that there may well be some good news from the Chinese and other oriental markets.

Good to see everyone taking "DYOR" seriously :o)

Happy Christmas to all.
ST

Al
The UK may not be that keen on Chinese medicine but a lot of Taihua's customers are abroad, in China, Russia and South America and the expansion will come from the application process for licences and approvals to supply some of its products to drug manufacturers in South Korea and Europe. I see a lot of upside in this stock short term 40p+ imo.

And I hope you make enough to retire on , Driver & ST, its just not one I fancy.
I sincerely hope you are right, I really do.
Unless you are a tax inspector or a traffic warden, in which case I hope you remortgage your home, put everything in them, sell your kids into slavery to buy a few more and then watch them go bust, which will make you mad enough to commit suicide and hopefully get it wrong, so that your death is slow and agonising.
But thats just the view of one who has had a tax demand and a parking ticket on the same day.
Other than that, I look forward to being very wrong.
alan

Well said, Alan. Taihua is a very risky share not suitable for orphans and widows.

92 % buys and yet the price falls - don't you love the mm's?
Tree shake for the beers till Tuesday!

Still down a bit from the early post-IPO high, but ticked up today: TAIH Bid: 16.5p Offer: 18.5p Change: 0.5

nudging up again: TAIH Bid: 17p Offer: 18.5p Change: 0.25

A tick up a day keeps the bailiffs at bay.

Right - if it added a quarter of a pee every day we'd all get rich :o)

Soul hi,have been watching these for the past 12 months and finally dipped my toes in at 16p,i have to say that its one of the few aim companies making consistent profits and growing at a reasonable level.Have only bought 35000 but expect to see good growth with results out soon and particularly like the fact that they are trying to expand into europe later this year, that could be a company maker.With more drug registrations in the near future hopefully they will continue expanding.Six months profit to end of June has nearly equalled 12 months profit for 2005 so am hoping for sparkling results in next 6 weeks.It appears on paper to be a very undervalued stock at present and if you have any more info please could you post.
regards, pisces.

pisces
Me and soul are out.

Pisces, thanks for your post. Good luck with your investment. I see from an RNS dated 05 Feb that TAIH won a license deal to sell Paclitaxel in S. Korea, so clearly they are making progress with achieving their stated aims.

Other than that I haven't had time to check on this co as have been busy in Jan/Feb with an international house move.

Great results out today,hopefully just the start of good things to follow.If there is some positive press over next few days we could hit 20p very soon,anyone wanting to make a quick short term profit should seriously look at these.

get on it

these are going 20+ in the short term, then who knows where when they enter euro market

Nice rise again today hopefully media coverage will pick up over weekend and put Taihua on the radar,most of the shares are owned by the directors so continued buying should see further gains early next week.

Apparently a broker note going out with a 45p price target,plenty of upside from here.

This share is too volatile - was +4p this am, now +0.5p.

just buy and walk away, come back at christmas

nobody want to get rich then?

I do.

hope you've bought then and your dreams will come true :)

I've bought in and looking to add as and when. This is definitely below the radar at the moment but not many shares available only 8% of the company which will make it hard to buy in decent quantity and hard to sell again until more shares are released for liquidity. However the hospital contract numbers released at the AGM
are quite amazing!!

great stuff moneyplus. i reckon this will be one of the stocks of the Autumn. easily surpass the 30p barrier on more news

this and FXPO of course! ;-) .. another one bubbling under the radar of the masses

get ready for breakout peeps

Hope your right, I just got in this morning at 22.5p. Good luck all.

Nice 55,000 trade gone through.

oilyrag it was pointed out on advfn that it's hard to buy in large volume when the price is going up, so a day like today is probably the best time to get in, when you can grab a few. Some posters were havng trouble buying more than 10000 when price is heading north..

Just bought, i really like the story here. Some knowledgeable posters reckon this could be worth 250p on EU approval and still 5 times the current price on China prospects alone. Hard to get hold of shares but they indeed are gold dust.

and then theres the planned expansion into the U.S within 3 years, as mentioned in AGM

FROM ADVFN...

2 peeps notes from AGM..


xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx



130407 - 24 Jul'07 - 14:55 - 782 of 871


Main points received from my friend

2 shareholders turned up. one from Cambridge apparently.
R Tanner NED Chair/ M Wyllie CSO / Proffessor Ma (from PRC) / Translator/ Nomad & City PR

formal resolutions passed.

Plenty of questions from the Cambridge Shareholder.
My friend made copious notes of both the formal and informal meetings. Notes from both meetings below.

Q. Will there be a placing
A. No not at this time, the company needs to bed in and we have "alot of money in the Bank". We will only have a placing if we can deliver more. Delivery means expaniding into the EU / US and acquisitions. By that time we will have shown we can deliver alot more than what we did in the last results.

Q. What is the status of EU approval / timescales
A. The aperwork is due to go in imminently (next week or so) the EMEA has a maximum turnaround of 45 working days, so approval by 45 working days, altohugh that is worst case scenario. Should be alot sooner ddue to us having all the dossier of paperwork together and previously approvals of less purity than ours

Q. How do you expect to Ramp up
A. We will need a EU Sales Director and ramping up wil lbe in place, we have now gone into 1700 hospitals in PRC and 1000's of clinics and pharmacie and have both short and long terms supply contracts in place and the trees are sustainable and our first harvest is in.

Q. Short and Long term goals
A. Short term Paxlitacel in EU
then injectables (huge margin on these)
then US approvals and market penetration

(Informally ..Later found out that M Wyllie works on a three year timespan. he is expecting to not only break into US within 3 years but be a major player there)

Q. Is there a broker note due
A. broker note is due and they will be having interviews with press and journalists today tomorrow etc. Broker note out with interims which need to be out by sept at the very very latest. Imminent was the word they used.

Q. Can the active ingredients be produced synthetically.
A. Yes, but no one will do it due to time consuming nature, and the quantity produced is in the milligrammes. Definitely nothing to worry about here as the timespan is very very long and arduous and not cost effective.

Q. Why do you not have progress reports or updates.
A. We were in the middle of a Board meeting, which will continue after the AGM. They were discussing that in length. and view is that that will happen shortly , progress reports on progress to date along with possible Q & A on the website. Website to be totally redrafted and MW agreed it was crap.

Q.Chinese companies have bad reputations in terms of Drugs, what do u see urself as

A.We are a WESTERN PHARMA COMPANY based in the PRC BUT operating to WESTERN STANDARDS at all levels. Very improtant to realise we are accountable and transparent in everything we do. And report to western standards, not PRC standards.

Q. What is world demand for PAclitaxel
A.World demand for Paclitaxel is 700-1000kg. we want to move to the high margin end asap, and our business plan is based on getting there. we are at 99.7% purity, better than any other worldwide. We want to get to.more. Eg he gave was he wanted 100%, becos as an eg, 0.1% of arsenic can kill someone, so they want to be nothing left to chane on anything.

Q. the Board and yourself have only paid yourselves 14k, is this because you are incentivised

A. we have share options, and the price needs to be at multiples of this.The plan is in place for us to achieve huge growth annually as shown in the last results.

My friend asked MW/RT his view on the SP in one year and three years based on current growth and US breakthrough. The price wil lnot be put on the BB's as WHI monitor the boards, suffice to say i was happy on reporting of their potential.


q. Timescales for Injectables
A. expansion of sales force in EU and US, then look at how to do injectables, cost study analysis being done. whether to d oit themselves ou outsorce. But they want to get into injectables

some other info: -

it takes 22 taxus trees to treat one patients cancer for their lifetime
1 taxus tree equates to 1 single does of paclitaxel

The Board are very very professional, they are looking to fastracke every single thing, and looking to speed up processes, the people like RT and MW are top of their fields and looking to make TAIH huge.

Main thing that my friend noted that this was a Western Pharma co in PRC doing things to Western standards. that is a huge boon.

Alot of the private discussions would not be appropriate for a BB.
Hope this helps.


xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx



0rb1t - 25 Jul'07 - 10:37 - 813 of 869


I made it yesterday to the AGM from Cambridge (5am start!). 130407, thanks to your friend for taking notes and making sure that I wasnt the only one asking questions!

I agree with what has been said except regarding the purity level of pactitaxel. Their emphasis was that they have a clinical purity level product far greater than some of the competition (I think the .1% arsenic was meant as a joke or to show that their extra purity level is important). Some more questions asked:

Q. What is the current price & demand for paclitaxel?

A. Very cagey on answering this. This was passed to the WH Ireland representative to answer. He stated that the increase in the price of paclitaxel (seen last year) had not reduced demand.

Comment: This is good news. So turnover and margins have at least been maintained.

Q. Have there been any supply issues in obtaining raw materials for paclitaxel?

A. Our supply agreements have ensured the raw materials required.

Q. In the prelims it was stated that 250,000 trees are required for current demand, how much does this equate to in the finished product?

A. Explanation was given about how the trees are grown to 5 feet and then chopped down to 3 feet and then allowed to grow again. MW then confirmed that 250,000 trees was equivalent to 50kg. He also stated that the plan was source 70-75% of raw materials inhouse.

Comment: Subcontracting seems prudent as this reduces fixed overheads and allows for demand fluctuations.

Q. Currently you have capacity to produce 50kg of paclitaxel. When do you expect to reach full capacity and do you have any plans for increasing capacity further?

A. (Market sensitive question). MW said that they would be looking for 50-75kg when selling to the European market and then higher if they break into US (US has 40% share of global market).

Comment: This is the first mention I have heard of 75kg. Current facilities (50kg) and supply contracts could reach this target.

Q. Are sales to South Korea meeting expectations after the licence has been awarded?

A. The initial contract has been supplied (Market sensitive question answered by WH Ireland).

Q. Isnt the Traditional Chinese Medicines a fragmented market and would this provide opportunity for acquiring other companies?

A. It is but they are concentrating on selecting fewer medicines that they can sell more of. All new medicines would be cost-justified. Want to concentrate on fewer higher demand products that would have a bigger market. (It sounded like they were going to be reassessing the new TCMs that they have recently applied for)

Q. Is there a market leader in supplying APIs and TCMs?

A. No significant supplier. Different companies may sell more TCMs but less APIs. (WH Ireland)

Q. Has the dispute with the constructor of the Xian office been resolved and what is the purpose of the new building?

A. The shell of the building has now been completed. Work is being performed on the interior. We are expecting it to be ready in October. No extra fees have been paid to the contractor. (the only question answered by the Chinese)
MW added that the current facilities were cramp and that it would house the staff necessary to administer the expanding business. A picture of the building is on page 8 of the annual report.

Comment: The new building looks quite impressive from the outside and is suitable for the image expected from a Western run company.

Other notes:

The 1700 hospitals referred to by the WHIreland rep is a lot higher than the 302 hospitals stated in the prelims. He confirmed this twice stating as mentioned in the finals. This could be a mistake or perhaps hes preparing the next broker statement!

Homoharringtonine has been approved in the US market but not in Europe yet.

TAIH expectation for global demand for 2007 was in the range of 700-1000kg. This provides more upside than the 700kg only mentioned in the admission document.

well it has to be one of the finds of the year for me. Have a good friend who works for a broking house linked closely to the company, he couldn't talk these up enough Tues night after the agm in Manchester. they were talking of 300p no joking.

kate bates
That would give it an M/Cap of 216m ???????

find that hard as there were only 2 shareholders present at AGM and both of them have posted their notes on the advfn thread LOL..

Ive just posted them here

a good market day and we could have had around 27-28p. We'll wait though.

ahhh, she's off again.

certainly a pretty stellar performance, but i suspect very low cap (can't be bothered to go to stock exchange page to check) and very much fringe stock in all respects ...... not for me, but good luck to anyone who is brave enough

cant be bothered to check but can be bothered to post meaningless drivel

says it all really your name dont it

well if you are such a smartarse why did you not post the info?
for those want to know, cap is a bare 15m with NMS of only 3000 shares, which indicates very restricted liquidity.

perhaps smartarse would now like to check who has major shareholdings and post accordingly

employees and directors hold 85% of the company as incentives as the entire board only pay themselves a total 14000 pounds! 15% free float does mean restricted liquidity hence the sp dramatic rise when everyone wants a piece of the action. Having said that I had originally 35000 and no problem selling but now back in again and could only get 12000---you have to buy in small batches.

thanks for clarifying M+ ....... a brave stock to buy and am surprised that authorities allow just 15% free float ...... of course, just as the rise can be dramatic, any pressure and the fall is likely to be truly melodramatic

should do some research, they've pots of cash pe is barely 10 and they are about to release a product worldwide. If this doesn't multibag i'll eat my knickers.

now that i would like to see... lol

sorry to be a wet blanket, but such ill-founded euphoria has been seen in many stocks before ..... you may be right, but if there is even a sniff of disappointment then your knickers may well not taste too good ..... as a simple example, take a look at the performance of TMC over the last few days, and that was just on the back of some delays in getting equipment; hardly a profit warning!

looks like Cynic is fighting it and missed out. Bitter sweet symphony.

yeah bye cynic

better fastest finger first

he can't leave it alone, think it's called jealousy.

not at all ..... why is it that there is such exception taken to those who post advising caution or even sales? ...... my reasoning for caution is every bit as valid (one might say more so) as your is for buying

err, did you read the notes from the companies AGM which states sales are up from recent results

durrr

DID YOU READ WHAT I WROTE?????????? ...... DURRR!!!!!!!!!!

clearly not!!!!! ...... but briefly ....
this sort of stock is very dangerous to trade, not only because it has very low cap, but is singularly illiquid with only 15% free ...... it is basic fact that while these mini-minnows can indeed rise like a rocket, at the slightest whiff of anything untoward, can (indeed will) fall like the proverbial stick or even a stone ..... further, unloading any volume can prove almost impossible.

thus, i have merely posted a sensible and logical caveat, so that those who jump in are forewarned

mummy's little soldier protecting all around him, can picture you now with a tank top, u a librarian??? Alot of my blue chips have lost 5%+ this last 2 days, seems they can be more dangerous than smaller stocks!

what is it with you? ..... i disagree, so you have to get stupid and personal

lol! just seen you post on the COH thread!! thought you didn't like illiquid tiddlers!!! Found out. Go and put jealous guy on your record player young man.

DURRRR!!!!!!!
I have never held or shorted COH
if you read properly, you would have gleaned that readily and that also established that it is a stock and even micro-sector for which i do not care ..... however, you are so eager to be ignorantly personal that you made a basic error ...........

had i written here, "Don't buy!" without any supporting logic, you would have had some justification for acting like a girlie with severe PMT ...... but you don't!

hey oilyrag

hope your still holding mate!!

so you just drift around threads advising people to buy/sell. Sounds like you need to get a life young man, care for a pair of my nickers to smell?? You can have the arse end as you wouldn't know what a woman smelt like it would seem!!

cynic get rich and buy

i see they are paying 30p for these now ;-)

only joking kate :) good luck

thanks, and i dare say your investment will prove a genuine gold mine, but as i said, not for me ...... unlike you, i have no need to be pathetically personal ..... by the way, i am assuredly a lot older than you, and for all you know, perhaps perhaps my sexual proclivities are more inclined towards sheep, horses or even dogs!

or was it deep sea diving cynic ? :)

enjoy scuba a lot, though am sorry to say have not now done so for 3-4 years ..... first tried it on my 50th and then dived every year in warm waters only(!) generally in between visiting our offices conveniently situated in Houston and S'pore

Yes dynamix, I'm still in and considering long term hold.

Kate Bates, as a form of compensation, should the sp collapse, may I offer to help you eat your knickers. lol.

Cynic, sorry Richard didn't mean to give you any grief, but sometimes it can break the boredom of some BB's.

Nice gain today, up 22% I am a bit suprised at how quickly its going at the mo.

that's ok m8 .... you know it never worries nor offends me .... however, it still amazes me, though it shouldn't, that if one doesn't follow the flock, one is almost invariably castigated for that contrary view, whatever its merits.

i would normally agree, but not in this case, theres no stock (hardly) and profits/sales are massively up compared to what the market were informed at float..

I've been having in depth discussions at work with a few PI's and they are also into this one. Apparently some of the more experienced traders on ADVFN are talking of 3 per share. Question is, how soon may we see this, probably at least after EU agreeing trading, and entry into the US. Another cause for concern is the length of time of tie ins for the board, any selling by them will increase the number of shares in free float causeing a dilution effect on the SP. As previously posted this is currently under most peoples radars, but not for long. Soon we shall see the hot money coming in. This will be followed by institutions as the market cap rises, this in turn will create plenty of trading opportunities as they like to buy in cheaply. I will almost definately top up my holdings on Monday, but feel that there will be a bigger queue than usual. This will move up again next week, but how quickly?

don't ever say i don't listen or pay attention!!
in a dire market yesterday (monday likely to be no better), trade in SAIH was 1.6m shares against a 3 month average of only 148k.
sight unseen the conclusion would be that sp totally tanked, whereas it actually rose 7p (25/30% if you wish).
what is not obvious to me, but someone who perhaps uses L2 may have a clearer view, is where all these shares (a) came from and (b) where they went.
for example, one sometimes sees hedge funds and similar swapping their holdings between their own funds - i.e. an internal move.
i also don't have a calc to hand (may work it out later), but what % of the total free float does 1.6m shares represent?

http://www.growthcompany.co.uk/recommendations/257689/taihua.thtml


Taihua - SPECULATIVE BUY

Companies: TAIH

27/07/2007

China-based Taihua, a producer of clinical-grade anti-cancer compounds, plans to inflate its sales and margins by entering the European market.

The group, where co-Viagra inventor Dr Mike Wyllie is a director, has been producing anti-cancer agents paclitaxel and homoharringtonine for over a decade. Management claims the difference between Taihua and competitors is the high purity of its production 91.7% meaning little or no further refinement is required before clinical use.

These agents are both derived from yew trees, bought from local farmers, and a single tree is needed to gain enough ingredients for one dose. In 2005, Taihua bought land to grow its own seedlings and has 60,000 young trees ready to harvest in 2009, this will present even more competitive advantages.

Paclitaxel has passed all necessary regulatory hurdles around the world, but for Taihua to supply to pharma companies in the 1.25bn European market it will need to garner its own EU approval. Further on, it will go through the same process for homoharringtonine, which has anti-leukaemia properties, and even further on an own-brand injection is planned.

A second leg to the business is its traditional Chinese medicines division, which concentrates solely on the domestic Chinese market, and as yet provides only a small portion of sales.

Brought to AIM last December by WH Ireland, the cash-generative business grew pre-tax profits by 74% in 2006 to almost 2m on the equivalent of 3.4m turnover. Sales, currently focused on China, Russia and South America, will soar if EU approval for paclitaxel is granted.

The shares have already rocketed from their 10p issue price and look like providing an interesting speculative ride.

Oliver Haill

Market cap: 23.35m
PE Forecast: n/a
Share price: 28.75p

oilyrag..


directors are tied in until December before they can at offload any at all..
if you read the AGM notes, they were questioned on the low wages they take from company... they said they have options on shares, and have a 3 year plan of huge growth of the investments in their own company and moving products into EU and USA..

I guess taking no wages leaves extra profit in the accounts which adds to the growth etc etc...

but is there any real incentive for them not to offload market-affecting slabs come December?

the price rise .. and the the likes of the article above.. are not factoring the move into USA .. it wasnt mentioned in Results.. or at float.. but has been mentioned at AGM... plenty more potential

maybe.. maybe not..

I guess they might want a BMW for Xmas? ;) .. but Im damn sure if they have a 3 year plan to become a major player in Europe and eventually USA.. they wont be doing a Gordon Brown and selling at the bottom lol

wrong question but got the info

US is much much tougher too

madoctor..

courtesy of JTCod on advfn..

take a look at BIP

http://www.bioxelpharma.com/docs/RA2006/BioxelPharma-2006-Annual-Report.pdf

not a Chinese co. , but have recently been given EU go ahead with no problem at all even though the purity of BIPs product is 96% against TAIH's which is 99.7%.. bodes well for TAIHs EU application..

Also note a question to the board from the AGM notes posted earlier on this thread..

Q.Chinese companies have bad reputations in terms of Drugs, what do you see yourself as

A.We are a WESTERN PHARMA COMPANY based in the PRC BUT operating to WESTERN STANDARDS at all levels. Very improtant to realise we are accountable and transparent in everything we do. And report to western standards, not PRC standards.

infact read JT's notes.. was a good read just after results...

http://www.advfn.com/cmn/fbb/thread.php3?id=13384181&from=285

bip calling their products drugs so i take it they have been tested

report writing so small on acrobat i can hardly read it!

very interesting reading but suggests to me taih have no intellectual property and the hope is that taih can produce cheaper than others or am i wrong?

thanks for taking the trouble to reply

i know i am a numbskull, but going back to the Q i raised on post 115, i reckon there are barely 10m shares for free trade .... that being so, it would seem that something like 16% of these were traded on friday! ....... surely an awful lot must have been internal fund x-trades, perhaps to massage their performance figures - i.e.seemingly to realise profits

Cynic you are right to question what appears to be yet another ramp of AIM floated Chinese companies.

i didn't actually say that, but i do love the following extract from post 123 ...... "We are a WESTERN PHARMA COMPANY based in the PRC BUT operating to WESTERN STANDARDS at all levels." ...... politely put, very much politician's speak!

I dont think its a ramp, they genuinely had a huge growth in the last results which the market had not priced in since the float.. until any of the speculative news like Europe etc come firm then I wouldnt expect us to break high 30s... high 30s is fair value for the shares available..

maddoctor.. you can zoom in on acrobat you know!

dynamix , thanks for that info , rarely use it but will not have to sqint next time

always good to see the derampers on board so early, watch the bitterness, they've either not bought or sold too early - usually took their 150 profit and now can't stand to see others make lots of money. The ones who have never actually held the stock are, in my eyes the real sad cretins. If only they spent their time researching stocks instead of jumping on b.boards of winning stocks trying to trick people into thinking they are concerned!! How sad are these individuals?? What do they get out of life?? They're not short, the stock cannot be shorted. I remember a certain poster on SOLA at 125p saying it was all too good to be true. Parasites.

do hope that is not aimed at me, for if so, totally unwarranted .... anyone is perfectly entitled to their view and opinion, whether or not it falls in line with that of the sheep .... as for "research", imo it is often highly over-rated, always depending on what one means by the word; the only thing of interest is whether or not the share is likely to rise or fall, the view expressed hopefully being backed with some kind of logic .... btw, i suspect one could quite easily short this stock, for it only requires a holder who is prepared to lend it.

if the criticism is aimed at me , i was asking questions because this has been on my radar for some time and my interest picked up when somebody said this company will be worth 3 a share. asking questions is NOT deramping and your reaction suggests nervousness. if this share is worth 3 it will get there no matter what i ask.

the word "hype" has been removed to take account of your sensitivities

for de-ramp go to the SER thread post 905

doc ..... a lot of peeps on this BB get very uppity if you step out of the party line ...... anything that questions or disagrees is deemed by them to be de-ramping, though why the converse should not also apply beats me! ...... i get a lot of flak because i have the time and inclination to post a lot, and frequently throw cold water (common sense or reality i call it) on the hype ...... this can equally apply to stocks i hold about which i am open or those i do not, about which i am also open.

cynic , i watch your posts often enough to know how you post and agree and disagree with you :-)))

on this one i had genuine hopes and thats why i asked the rather uninformed questions due entirely to me being a technician (or trying to be) as opposed some the fundamentals peeps. In other words i care little about the company only about the share price but do like to understand a little about what i am getting myself into!.

in my more insane moments, i too am tempted by this stock, but it is pure greed, especially with the markets looking very wobbly indeed ...... there is an awful lot i do NOT like about this company, in particular that it is Chinese and Chinese-controlled despite the spin that the CEO tried to put on it, and also that there is only 15% of the equity in free float ..... as it stands, it looks to me that the sp is taking an awful lot for granted, specifically that their drugs ("wonder snake oil" or whatever) will be approved the EU authorities ..... US FDA will be a substantially bigger hurdle ..... in any case, it is all a long drawn-out process and you only have to look at the substantial pharma companies that have really struggled or even failed to realise how tough that route is.

best leave them to it i think

maybe ... only entered the fray because i was asked to by a "friend" on another thread

cynic, would welcome your view/comments on FOGL !

but would the other posters ROTFL! .... will take a butcher's

lol

go on dynamix; take a peek, i dare you.... one of my more intelligent posts there

Topped up again at 28p.

brave boy!

Hi Cynic.
Just wondering about your Snake oil comment.
As far as I am aware their drugs are well known anti cancer drugs used by many.
The purity of their drugs are well ahead of the competition at this time.
The last company to get E.U. approval, their product fell well short of Taihua`s purity, so I would suggest that approval is just a matter of signing the required document.
I would add that I think that this approval is probably reflected in todays share price so it has to get approval.

you are the supreme optimist if you think getting EU approval will merely be a rubber stamping exercise that will be done any day now ...... many many people use all sorts of strange lotions, potions and concoctions, some of which may even contain the purest snake oil ..... these same people may also swear blind by their efficacy, which for them, may even be well-founded as opposed to mere placebo effect, but that is a very far cry from the same lotions, potions and concoctions being granted the relevant EU (let alone US) drug approvals

cynic.. TAIH are in process of submitting EU application, application can take MAX 45 days for approval/rejection

I take it then you don`t like the Chinese, and that you think they are a nation of liars.

porky, he doesnt like anything it seems .. full stop

new age Victor Meldrew is cynic

more than happy to be labelled as a new-age sometime purveyor of common sense and reality .... rose-coloured glasses a la Sgt Pepper and Mr Lennon are of most questionable value ...... as for my view of doing biz in and with the Chinese, that is already well-posted from first-hand experience.

Appears very negative when a successful company is staring him in the face Dynamix.

Very nearly a racist remark Cynic.
Shame on you.

porky

if cynic went to a casino he would twist on 21!

LoLLLLLLL.

not at all racist, though if you would like to look at some of the pretty rabid views held by some on this board, have a look back at the thread i raised about whether immigration was a bonus or a bane to a nation.

as for whether or not TAIH is indeed a successful company remains to be seen some time well into the future ..... even then, as now, it will be possible to make money by being either long or short of the stock, always subject to timing

the countdown begins

45 days maximum

i watch with interest but no financial involvement - lol!

i thought so!

u already knew i did not hold nor, on reflection, had any intention of doing so

Mr C, off topic a little, this thread was started by ST. Any idea what has become of Soul.

Thanks.

your right! .... i know he now lives in B'mouth, but have unintentionally lost track of him myself .... will try to remember to e-mail him.

yeah like i said, i though so

Topped up again this morning, all trades showing as sales when they are buys.

one and all .... have been in touch with good friend Soul* .... he is alive and kicking in balmy (barmy?) B'mouth ..... no doubt he will be back on line in due course

Thanks for the update Mr C.

Should be rewarding when sanity returns

Interesting share, should do well if AGM feedback is acurate. Low cost base, high margins and correct me if I'm wrong but one of the directors responsible for launching viagara onto market, good pedigree if true.....must do some more research!

BTW... EU application for approval is within 45 business days for your info.

Tangle, don't take too long researching, it may be too late.

+/-14th September looks to be the key day for this company.

my birthday! how nice that would be :)

that depends on whether or not the news is as you hope!

Major shareholders sells stake see RNS

here you are ..... and note the thumping discount at which he sold, presumably being the best he could get .... note too that if my maths is correct, he used to hold nearly 12% .....

Biopharmaceutical company Taihua PLC said its substantial shareholder Hong Zhou has sold around 9.1 mln shares of the company at 22 pence a share from Aug 7 to Aug 9.

The company said Zhou now holds about 1.17 mln shares, or about 1.45 pct of the issued share capital.

dynamix + kate barnes and others ...... how very very very quiet you have suddenly become ..... my post on 27th July is below, and quite a lot of abuse it brought too ...... some humble pie must be on the menu for some, or dman well should be!

"a brave stock to buy and am surprised that authorities allow just 15% free float ...... of course, just as the rise can be dramatic, any pressure and the fall is likely to be truly melodramatic"

no one likes a smug punter.

Im still long as I hold from morning of results!.. but another 3p down and Im out for evens grrrrr I would have sold at 20p had I been around but went away for a few days and this happened.

dynamix, where's your patience. During Sept you have a brokers note due out from W H Ireland, you have the interims due and you have the result of the companies application to trade in the EU.

The sp on Taihua has dropped like everything else. To sell now is madness, have courage in your convictions, afterall the fundamentals havn't changed on this company.

As soon as the overhang from the 9million shares from director dealings has evapourated then the sp will start to rise. If you all panic and sell then all you will be achieving is to increase the overhang and prolong the wait for the more patient among us.

I do have courage, but I dont let winners change to losers (anymore!), and never get emotionally attached to a share


still holding though for now

you also need to be aware the worlds markets are on the verge of meltdown.

fundamentals wont matter a stich if that happens

Nor will the cash you get for any of your shares.

On Friday they were selling Taih under the mid price. I suspect the same is happening today as there are two groups of prices on todays trades. Around the 17p are sells and 18p are buys IMO. Can anyone confirm this.

Sudden jump in sp would suggest that I'm on the right lines. Here's to a hopefully prosperous future.

i'll be boorish and say it again ..... all fine today (maybe), but learn the lesson of what happens to this type of stock when the market turns sour again

what are you ? some sort of knight in shining armour ?

Im sure we all know the risks , or should do.

by the way , TAIH rocketed from 20p to near 30p when the markets were getting "sour"

The extreme market turbulence we have seen the last couple of weeks has turned even the best stocks sour. Im not worried unless it gets back to my buy price and I have to sell :(

as you might say to me, "When I need your advice, I'll give it to you"

?

lol

Just topped up another 10,000 shares. Not long now.

good stuff, I'm still hanging in here, good to see it back above the results spike again

looks like this could fly, absolutely no stock around and MMs trying not to deal.

I unloaded half of my holding today in 2 lots

very happy from 13.5p , I'll sit on the rest of them for now

can't be wrong to top slice .... TAIH, perhaps more than most, is totally and utterly unpredictable as free float is far too small for comfort

will most likely go further up come November, but Im now in a comfort zone for September and October

Speculation about brokers note due out at end of Sept, has risen from 45p to 80p.

80p price target? sounds nice. Just in from work, noticed they knocked it down but advfn forum says you couldn't buy any near the end! Think i'll have a few more on Monday morning.

assuming bernanke does not disappoint this evening, then markets could be rocketing yet agin on Monday - which of course is the time to be aware that there will be almost inevitable over-reaction upwards, with an ensuing bump down.

Hope you are right about the move up I think we can handle the move down when and if it comes!!

Wall Street currently (18:55) +145 and has been at least 50 higher ......

now go to http://money.cnn.com and read bernanke and bush on this issue ...... long w/e in US just starting, so hard to know how Dow will finish .... my guess is about where it is now, which i take as a positive sign

From Proactive investors 29/08/07

Market: AIM
Shares in Taihua have been one of the star performers of late on AIM. After raising 782,000 before expenses at 10 pence per share in December, and initiating trading at slight discount to that, the shares have easily outperformed the wider market. The bulk of the capital raised at listing was for the cost of listing, with some spare change left over for working capital. Taihua didnt require additional cash as it is already a cash generative business, highlighted in full year results for the period ending 31 December 2006, which showed profit before tax of 2 million on revenues of 3.48 million impressive margins - and up 74% and 64% on the previous year respectively.

Taihuas primary reason for listing on AIM had more to do with the groups short to medium term ambitions; we will come back to this later. Taihua produces active ingredients for use in medicine. A little known fact is that more than 50% of all medicines are derived from plants. The many plant species used in medicine are harvested and purified to produce particular ingredients, which are then often converted into pills or injections. Sometimes other ingredients are added to help with varying issues such as dissolvability in the blood, or consistency for making into pills. The key point, however, is that many of the active ingredients in many of the drugs we use everyday are derived from plants. Taihua is one of the companies who extract the desired active ingredients from plants into a form ready for use by drug manufacturers. There are a number of factors that come into play when a drug company chooses a supplier of an active ingredient, but arguably, the most important factor is purity. Not far behind purity is cost and deliverability of the desired product in the right quantity and quality. This is where Taihua has worked on differentiating itself from many, many competitors.

Taihua is focused on two key areas. First, and not surprisingly, the company is licensed inside the Peoples Republic of China (PRC) to supply traditional Chinese medicines. This is a fierce market with over 2000 companies with licences. Taihua has an internal sales team of 56, and claims it is one of only 500 companies that operate in such a manner. The AIM listing wasnt to support Taihuas desire to promote Chinese medicine, however. The second division of Taihua is focused on two active ingredients used in cancer related medicine. The first is Paclitaxel, an ingredient extracted from the bark of a particular species of Yew Tree (named Taxus) which is relatively abundant in Northern Asia, India and North America. The drug was first commercialised by Bristol-Myers Squibb in 1993 under the brand name Taxol. Taxol is used in the treatments of many types of cancer, as it acts as an inhibitor on cancer growth by stopping cancer cells from splitting. Since Bristol Myers-Squibb brought the drug to market 14 years ago, it has generated revenues in excess of US$9 billion. The patents protecting Taxol from competition expired in the European Union and United States in 2003 and 2004 respectively which, not surprisingly, created a surge in new players producing generic drugs; as many as 55 companies in Europe and 12 companies in China, of which Taihua is one. This surge in competition and demand for Paclitaxel forced the Chinese government to restrict the wild harvesting of the specific species of Yew Tree used with the obvious impact on input costs and supply issues for Chinese manufacturers including Taihua, who sold less Paclitaxel in 2004 & 2005 than in 2003. Taihua decided to take control of its own destiny, and leased tens of thousands of square metres of land to grow its own supply of Yew trees. This investment is nearing pay day, with sapplings planted now ready for harvesting in two years time. The company has a 10,000 square metre estate for seedlings to grow, which are then transferred to a 34,000 square metre estate to mature and harvest. This offers Taihua a considerable advantage over its competitors as it has taken control of the single largest risk to its business the cost and reliable supply of raw materials.

Taihua isnt a new company; having been established 13 years ago and focusing on traditional Chinese medicine, it brings considerable experience to the supply of active ingredients. The company has already secured licences to supply Paclitaxel into Russia and South Korea, and has third party distribution agreement for South America. This logically brings us back to Taihua and why it listed on AIM no prizes for guessing. Taihua has its sights on regulatory approval in Europe, which will first require a Good Manufacturing Practice Certificate and then a Certificate of Suitability. Once those are awarded, which Taihua stated in its listing documents that it anticipates in the second half of 2007, a country by country approval process, that will likely take at least 2 years and several millions of pounds, will be required. No clinical trials are required, but Taihua does need to show that its product is a bio-equivalent to Taxol and that their quality of product is of a high enough standard for western regulators, and that their manufacturing process is in compliance with western standards. So a lot of hoops to jump through, but the end game is the ability to supply a high quality active ingredient into one of the largest drugs markets in the world, and to be able to compete on cost by having their own supply of raw materials in China.

Taihua also produces Homoharringtonine, which has been used in China since the 1970s to treat acute myeloid leukaemia. Recently homoharringtonine has undergone clinical studies and received clearance in the western world for human use. Homoharringtonine is now undergoing various clinical trials for use in the treatment of a range of cancer related illnesses, and it is for this reason that Taihua has been increasing its production from 0.5 kilograms in 2003 to nearly 9 kilograms in 2007.

Meanwhile back in China, Taihua has benefited from installing its own sales team with group revenues of Chinese medicines rising to 622,000 during 2006. The company now sells traditional Chinese medicines into 302 hospitals across 10 provinces and supplies, through third parties, a further 1174 clinics and pharmacies in 13 provinces. Taihua sells seven plant-derived products all targeted at the cancer market.

As of yet, House Broker, WH Ireland, has not provided guidelines on revenues for 2007 and 2008; however, Life Sciences Analyst, Oliver de Giorgio-Miller, said that the consensus from the company and the broker was that growth would continue at a strong pace in the current financial year. More specific details dont exist yet, but a maiden research note in the 3rd quarter should help clear up exactly what kind of growth prospects are on the horizon for Taihua.

proving impossible to buy a good amount this morning as per bloody usual. Getting fed up with being stuck at work when this stock goes down and not being able to buy ( works firewall). Just rang up to buy 50000, quote "27 and a third pence" nice that they want to add just 1 1/3 pence on. Greedy barstards.

perhaps a silly comment for a change, but why do you not just leave an order with broker at a set limit, with acceptance of partial fill? ..... of course, you have also highlighted the prob of stocks with minimal float/liquidity, both when heading north or south

Yes i should do really. Think i'm trying to be too smart and catch perfect timing. I'm not sure there's a liquidity problem, more the old marketmakers playing the usual manipulation game. Apparently you could have bought 25000 on friday and with no apparent big sells or big buys (there was a few decent buys right at the bell on friday) you now struggle to buy more than 5000. Of course the dreaded MMs have to 'earn' a living though..

MM's buying at mid, they are desperate for stock. This should really start to move soon as long as everyone holds on.

looks like this could be a big blue day, stock being bid for at mid price and people paying over the offer, looks like a few have done their homework.

be careful, chinese stock market 'due an inevitable collapse' according to the times, whilst this won't have much of an impact to this company's profit it will hammer sentiment of chinese stocks. I may short SOLA this week.

i think SOLA is a good short anyway, enhanced by its "china factor"

ITS ALL GONE QUIET, THE SP ON THIS STOCK IS ABOUT TO BREAK OUT AT A FANTASTIC RATE, AND NOBODIES TALKING ABOUT IT.

MY MATE RECKONS THAT IT TOOK SOMEONE NEARLY 3 HOURS TO COMPLETE A TRADE FOR A FEW THOUSAND SHARES THE OTHER DAY.

DONT BE FOOLED INTO THINKING THAT THIS IS WORTHLESS. FAR FROM IT, ITS ONE OF THE BEST PLAYS OUT THERE AT THE MOMENT.

oilyrag
Well I can buy 30k shares with Barclays no problem.

PREHAPS YOU SHOULD CONSIDER IT. IMHO, DYOR.

DRIVER, ARE YOU IN YET? +0.75P SINCE YOUR LAST POST.

oilyrag
Was in I got out in April, no funds at the moment but still on my watch list.

results any day and hopefully soon a european license. Possibly a nice spike and then the usual sharp drop-plenty of time to pick some up but it's almost impossible to get any when they spike up so buy on dips if you fancy some. lol.

Someone from the other side has phoned W H Ireland, and they have confirmed that the results will be released today. I have just topped up again.

Not as good as I was hoping for, and the reaction to the results might be continued drift now.

pp I agree but it makes sense to fast forward the push to get US regulations at the same time as europe--preparations and paperwork must be the same so costs will be cut presumably. When the permits arrive so will the rockets imo until then back to sleep or add on dips!!

I wonder how long this protected buy trade is going to last, and how many more shares its for. Once its out of the way and any residual T20's bought for results have expired I think this stock will appreciate considerably.

Weds 17 Oct is the expiry date for T20's purchased for interim results. After this I would expect a considerable rise in SP.

I hope so Taih have been very dull lately--great prospects though and a brokers note expected very soon according to the other side.

Its not been dull mp, its been manipulated and controlled to freeze out the hot money. If you look at this medium term you will make a fortune.

I agree.. hopefully mega bucks for the patient-no pun intended!

is this another rocket revealing its true self as a stick?

Hi cynic, have a little faith. Judging by its rise, late on Friday, with so few trades, this is a rocket waiting to be lit. The fundamentals of this company are A1. They are profitable and are about to be in a position to vastly increase their customer base. All excellent prospects in my book.

Ramp on oily we all remember TMC!!

broker note is out, but can only be accessed via your own broker if you have an advisory service (you need to ask WH Ireland to forward a copy to your broker).

has anyone spoken to their broker to see if they have a copy?

great company with good prospects, but flagging due to lack of news.

broker note, if made available to all of us, should show (strong) forward earnings for this year and next, which, apart from alleviating some apprehension current holders may have, may also persuade others to invest based on potential upside.

all imho

Latest WH Ireland Brokers Note


Just click on the "download file" link.

Someones stakebuilding. If they push the price down to 14p, then I would double up my holdings.

The way this is going at the moment oily I would be getting my money ready!

and if i were you, i would steer well clear

looking back at a number of posts in late july at around numbers 90/100 when sp was about 28p and i see i warned of the lack of liquidity in this stock with only 15% free float ..... not for the first time, i was roundly castigated ...... and then yet further abuse in mid/late august around posts 175/190

Ms Bates ..... i hope you enjoyed eating your knickers as promised!

and dynamix and others, how about eating some humble pie??

the broker note turned out to be overly conservative, but even on the 2.4p earnings quoted for this year quoted by WHI, TAIH is currently on a very low PE of just over 6.

its the lack of newsflow hurting this one at the mo. put in the bottom of the drawer, itll be up again at some point next year.... i hope!

it's the lack of credibility hurting this one ..... wishful thinking weill not make your fortune

what has happened to all the champions of this stock who were quick enough to throw brickbats at me several months ago?

Merry xmas and happy new year everyone.

can't imaginme that many will feel very merry if they bought into this stock ..... oh, it's not Chinese controlled is it?

Cynic some seem to disagree with you. Moving up today?

wowee! .... fine if you bought at 15, and that's about it!
just been reading back at the raves on this thread back in early august when price was 27p+
and what happened to this EU approval that was going to happen by end september? ..... certainly no rns that i can see

THIS THREAD IS NOW DEAD. HAPPY NEW YEAR.

This is far from dead, just watch over the coming months.

wow, really quiet, not much to say, im waiting for full years results.

even with the crap pr, how can the PE of 6 be justified for a company which has seen year on year growth?

cynic, u havent posted one of your 'i told u so' statments in a while. by the way since u seem so well infomred, any stock tips??

ill be adding small amount in the run up to june, hopefully good results, but who knows, afterall this is the AIM.....

i may be opinionated and a purveyor of home truths, but certainly not well informed!

if you keep your eye on BB, you will readily see the stocks which i rate as a buy, or even as a sell or avoid ...... if you have the nerve and application for it, the indices can be a source of fun as well as money

oily .... only very slightly sorry to tease, but on 3rd Jan you wrote, "This is far from dead, just watch over the coming months" ..... at the time, sp was about 17, so it has lost a further 20% since then ..... perhaps you also have a friend called Lazarus?

Hi Richard, the fundamentals havn't changed and as pp79 points out with a pe of 6 and cash generative someone is taking the pee big time. I am happy to hold even if its a bottom drawer share for a few years. Who the hells Lazarus. LOL.

Lazarus, of course, came back from the dead, like a good pal of mine who "died" about 6 times 2/3 years ago, but within 6 months or so was right as rain, or sunshine for that matter.

will one be able to say the same of TAIH?

The only thing that would concern me with regard to TAIH is if Dr Mike Wyllie decided to call it a day. He is the chief scientific officer for Taih and is responsible for bringing viagra to the market place. Therefore, with someone of his stature on board, the company has ambition and leadership. The real profits for TAIH will come in 3 years or so when they enter the injectables market. All in the future I know, but that is what makes this a great speculative selection.

meanwhile, you would be much better to put your money elsewhere

SO much for my warning, good luck.12.5p to sell.

BREAKOUT. BREAKOUT. BREAKOUT.

Obviously not a lot of intrest in this one on this site.

Someone purchased 137000 shares at 18p today, 2.5p above the offer.

More blue to come IMHO.

oily any news due?

Finals due by end of June. Currently sitting on a PE of about 3.

Increased demand and sales in China and S Korea.

No news as yet on US or EU licenses. Rumoured to be in line with injectables.

Approx 3 years until injectables are availiable, then this should become a multibagger. IMHO.

Had to top up today, rising nicely on any buying.

Final results must be announced this week.

Not in this one, sold a long time back and escaped at break even.

To me, they do not seem interested in their London listing, it appears to me that they only listed on AIM to assist with their EU and US approvals (the "listed on London FTSE" mark).

This would explain the absolute crap, imo, PR that Taihua has.

Its also explained by the small free float and also the minimal money raised on listing.

If this is the case, then I see very little point in investing in Taihua, as, they will continue to have crap PR, they will not plan to pay any dividends, and so, what value will be delivered to any shareholder ?


They also appear to be very happy to bump revenues by increasing debtor days and trade receivables...........so keep an eye on those figures from results, and the "net cash generated from operations".......if there is any.

concur with PP and recollect that some months ago i commented (as usual) about the wisdom of investing in chinese companies ...... i haven't changed my mind!

Pretty average results imo, but some scary details in there :


Margin down from 57.6 last year to now 55.4% - FALLING MARGINS

Inventories up to 8,104 from 6,150 - RISING WORKING CAP

WOW - Trade receivables up to 20,903 from 5,891 - RISING WORKING CAP

As I said, its easy to get revenue, just give the product away with a "pay when you want to" mentality.........thats the easy way to bump revenues. Always the worry when you see "trade receivables" rising through the roof.


Net Cash Generated from operations DOWN to 9,630 from 26,517


Some worrying signs in there..................but at least they are paying a wee dividend, however, the worries over how they are gaining business should be a concern imo.

P.power your a disgrace writing crap like that, what planet are you on ???

Price is going up PP, weither you like it or not. Excellent results and a dividend.

Just looking in -same old crap on M..A..M where PP regarded as sensible and his acolytes don't know any better. It might provide some entertainment if it weren't so tedious. PP can't afford his premier status on A..D..V..F..N -must be all those losses from LEAD ;-))

Margins falling.

Net Cash generated from ops, falling.


Worrying.

And this is only to Dec 31st 2007.

The bigger issue is will Margins keep Falling at interims.

From Jan 1st, higher labour costs due to the new labour law.
Rising price of chemicals
Rising price of transportation.
Rising price of energy.


Margins could fall further at interims...........

PP WHY DO YOU HATE CHINESE COMPANIES SO MUCH?

I don't hate them, I trade them..........

Its all about making money, not love or hate.

PP IF YOU TRADE THEM WHICH ONES HAVE YOU BOUGHT LATELY OR ARE YOU JUST ANOTHER SHORTER?

PP can't afford to short LOL since his credit cards were revoked. Saddest individual on the world's messageboards bar none.

Trading is buying and selling, long and short.........

Only Long Term Investors buy and hold.........and nobody should be doing LTBH on any AIM share........really.

LTBH is for main market stocks, not volatile AIM stocks.

pp that is no answer have you ever bought any chinese company shares, if so which ones?

WCC at 120p before its rises upwards.

TAIH at 15p a long time ago, and sold when back down to 15p as well.

GNG in the 20's before selling in the 50's.

RCG in the 40's before selling at 100p.

etc.etc.etc.etc.

Also, shorted them as well. This is the way to trade, be long and also short - thats what shares are about, making money, not falling in love with them.

Falling away fast now - AS EXPECTED AND PREDICTED BY....well PP :)

Sometimes is just so obvious what the rampers are up to.........and how easily they fail as well.

Denial in these market times is the worst enemy of the private investor.

They try to deny things are bad, they do this as they do not want to "sell at a loss" - they fervently search for people or writings that give hope and then comfort themselves that someone else is bullish.

They deny themselves the chance to benefit from market bottoms, by refusing to sell when markets tank, and then having no spare cash when markets really do bottom (FTSE circa 3K or 3.5K ?).

The deny to themselves that the rampers are rampers, that the people desperately trying to ramp prices up are in fact the same as them, trying to not sell at a loss, hoping that ramping will get prices up and they can sell at breakeven.

Denial is what causes PI's to lose - and sadly lots of people today appear to be in denial.


A simple an effective tool in bull and bear markets is, 20% down and sell. Any stock that falls 20% below the price you purchased, dump it, admit you were wrong to buy it at that time, preserve your capital, and move on. If its dropped 20% since buying, its plain obvious you purchased at the wrong time.....is it not ?


Beware of denial, its the PI's worst enemy.

Don't like some of your posts but in this case I agree with you.

What you say is true. The problem is that it is human nature to behave like that particularly in these markets and thus very difficult to change.

No excuse for ramping though and there has been enough of that recently on these boards.

Is this the same PapelPower that was ramping several stocks including Ast and Ipl
recently that have lost around 80% of their value ?
You create the impression of a person who lives in a fantasy world, you seem in
denial at all the very bad tips that you have gave out over the last 12 months and
you have this arrogance of a person who refuses to accept they are not very good
at what they do.
Sorry PapelPower but i can understand others that take a great dislike to you on here and other bulletin boards, you are a hypocrite and you contradict yourself on
many occasions, it all seems a ploy by you to gain attention, i dont think there is
any money involved here, you probably invent trades up, when a stock suddenly
jumps or tanks you have suddenly closed a short the day before or opened one
the day before.

Your credability is zero i'm afraid.

Good trading (if you actually do trade)

Perhaps you could name your trades ahead fo them showing to prove to others
that you are the expert you crave others to believe.

PP wrote, and quite accurately too, even if it is not his own "thought" .... A simple an effective tool in bull and bear markets is, 20% down and sell. Any stock that falls 20% below the price you purchased, dump it, admit you were wrong to buy it at that time, preserve your capital, and move on. If its dropped 20% since buying, its plain obvious you purchased at the wrong time"

however, it is a human trait that most are optimists and hate to crystalise losses and would rather take a (small) profit in Share A to realise cash than to cut out that dog of Share B.

Good advice there cynic!

I always use TA when opening a trade and setting a SL.

Under certain circumstances though (during generally poor market performance for instance) I will sometimes lower my stop but never by very much. In cases where the support/s I was counting on fail, then however bullish I may feel about the stock, I tell myself that exiting may provide the oppertunity to re-enter at a lower price.

-May not be a bad idea to simply follow your 20% rule but depending upon the volatility of the sp and the support levels, this level may not always be appropriate (sometimes too much, sometimes too little).

paul56, you appear to be a new name, and obviously one who is a little bit emotional that your stocks are losing.

The two examples you quote of AST and IPL, it shows you do not even research stocks and prices, you simply pick on two stocks you know nothing off, and start mouthing off about them. Is this because a couple of my stalkers have been posting rubbish about them ? LOL

Before I put you on squlech, which means I will no longer read any of your posts, let me point you in the right direction.

AST, many BB's (as I will update them from time to time).

First purchase was way back at 8p levels, since then it has risen to 34p, and fallen now back to 5.5p levels. Over that period of time from 8p to 34p and down to 5.5p if you have not made money, well, I give up.

IPL, many BB's (first purchases were in the 40p levels, then there was the West Bukha-2 drill success and rises to 60's, then it fell back, then RAK purchased the production assets of IPL giving all holders a special 60p dividend before a 1 for 5). At this point all my initial IPL shares become free and with profit. Since then I have added a few more at 20p levels.


So there, now you know. I would like to ask how you think you know how I trade stocks ? What price I buy, I sell, I rebuy, I resell, I short, I buy back etc....

You do not, you are simply just another voice of the sad failed rampers that are losing so much money that they get all emotional and nasty, however have to resort to total lies and falseness in order to do so.

Makes me laugh :)

So anyway, I will now put you on to my squelch list, so good bye paul56.

And if anyone is interested currently I have 4 posters on squelch.


Users you currently have squelched

zscrooge
coeliac1
holmes9
paul56


.

.

stop losses ..... in very volatile stocks or markets, you may feel more comfortable with a guaranteed SL, which guarantees the price at which you will be closed out .... an ordinary SL does not

PapelPower

Your angry response last night seems to suggest i was maybe a little close to the mark about you.
I've not revealed anything about me but suddenly i am a failed ramper who is bitter hence i've turned up here to have a go at you.
As i said before you are in denial, as a long term lurker of advfn i have watched you tip numerous stocks and it is/was quite clear you were long of these stocks just before they crashed but you again are incapable of being honest.
I think anybody who invests in a stock is entitled to be bullish just as much as somebody who bashes a stock they are short in, you are equally as guilty in that department by attacking certain stocks that i doubt you have a position in, i doubt you actually trade much at all, it does not add up.
And what do you do when somebody challenges you ? you run away.

All the best

Paul

The TAIH rampers running for the hills now ??????? ;) LOL

Hardly PP, real holders still there and not budging. Spread bets and roll overs maybe, or chancers who cant afford to invest with spare money being forced out. Their own fault, if they cant wait as long as it takes. You must be getting desperate the ammount of de ramping on a stock you reckon you no longer hold. Personnally, I wouldn't waste my time on something that I didn't hold or wasnt looking to hold. You either have a hidden agenda or nothing else to do.

sorry oily, but i don't agree ..... i take an active interest in all sorts of stocks that i don't hold and for all sorts of reasons

in this particular instance, i side with PP insofar as i have never liked either the stock or its chinese parentage, and have posted as such in late july last year when sp was 20s and been duly pilloried

Link to Annual Results PDF that contains more info than Results RNS :-

Taihua AR 2007 PDF

Whoops... !!!


Taihua plc
("Taihua" or the "Company")

Annual General Meeting Statement

At the Annual General Meeting of the Company, to be held at 9.00am (UK time) today, the Chairman, Richard Tanner, will make the following statement:

Following on from my report in the annual report and accounts, in respect of the twelve months to 31 December 2007, I am pleased to provide shareholders with an update.

In the six months to 30 June 2008, sales volumes of both Paclitaxel and Homoharringtonine are ahead of last year. However, adverse exchange rate fluctuations between the Renminbi and the US dollar have impacted upon the value of sales.

Although new Traditional Chinese Medicines ("TCMs") are ready for introduction into the market all TCM licences issued to Chinese companies since 2005 are under review. This lead to a suspension of production.

As mentioned in the annual report and accounts, we have submitted application to the European Directorate for the Quality of Medicines for a certificate of suitability for paclitaxel, through our regulatory agents Beijing Canny. We are still awaiting their feedback which is expected before the end of the year.

Finally, I can confirm that the Company has commenced the process of seeking regulatory approval for the payment of the dividend and a further update will be provided in due course.

Funny really, now if any of the rampers had bothered to check, they can quite easily see that Chinese exports (on lots of goods) are done in US$ but the US$ rates have not been corrected for the strength of the RMB.

So they are all still selling at 2007 US$ prices - say 100K US$ for "x".

But that was based on the RMB conversion of an RMB price into US$ in 2007. Prices remain static - RMB appreciates - sales levels in RMB go down the pan, along with margins.


And thats today's lesson in the perils of Chinese companies........ :)


Expect lots more margin erosion at the next results.........as I kept on about :)

All production is halted it seems :

Although new Traditional Chinese Medicines ("TCMs") are ready for introduction into the market all TCM licences issued to Chinese companies since 2005 are under review. This lead to a suspension of production.

sorry to see old pal oily getting whacked on this share, but i see neither dynamix nor kate barnes telling me that my warning a year ago was right and they were wrong .... why would that be do you think?

More trouble ahead for Canada.........door shutting there ? Will North America all be the same ahead......... ?


http://www.cbc.ca/consumer/story/2008/07/18/bc-tradition-chinese-medicine-regulation.html

Traditional Chinese doctors fight federal regulation under Bill C-51

Last Updated: Friday, July 18, 2008

Doctors of Chinese medicine across Canada have joined forces to fight the federal government's controversial Bill C-51 a proposed law that critics say will make many natural health products unavailable, including Chinese herbs.

If approved, the federal bill would treat natural health products like herbs, vitamins and minerals as drugs, making it harder to import, sell or dispense them.

Doctors of traditional Chinese medicine, or TCM, say their herbs would have to pass Western-style clinical trials under Bill C-51.

Dr. Henry Lu, who runs the International College of Traditional Chinese Medicine in Vancouver, said that's like saying, 'You can speak Chinese but use English grammar.'

"You should allow TCM practitioners to practise the way they have been practising," Lu said.

Peter Wood, who heads the TCM Association of B.C., said the bill would hobble Chinese medicine, and be a giant step backward.

"It's basically taking choice away from Canadians on which model of medicine they'd like to use," Wood said.

Five-thousand years of history has already proven TCM is safe, he said.

"I don't know of any cases of anything going awry. And if there are, there are far fewer than there are deaths that happen from pharmaceutical drugs," Wood added.

Bill C-51 draws national opposition
Those opposed to Bill C-51 are hoping to rally public support to quash the bill before it becomes law, which is expected to happen in the fall. Websites and online groups have sprung up across the country imploring people to lobby their MPs to halt progress of the bill.

Critics believe Bill C-51 will outlaw up to 60 per cent of natural health products currently sold in Canada, and penalize parents who give herbs or supplements to their children.

They also argue that the government could designate any natural health product a prescription drug, making it available by prescription only, forcing smaller companies out of the market.

Many natural health product retailers and holistic health practitioners maintain major drug companies lobbied for the bill, but the government has maintained it's about safety.

Federal Health Minister Tony Clement has defended the bill, saying that it will allow the federal government to continuously monitor the safety of products even after they have been approved.

Clement's office says the government will be proposing amendments to the bill if it passes second reading and goes on to the committee stage in the fall. If the amendments are adopted, natural health products would be defined within the legislation as a unique category apart from food and drugs.

Another proposed amendment would ensure that regulations specific to the approval of natural health products recognize the value of traditional knowledge and history of use in assessing benefits and risks, as is already the case.

Here is the White Paper, issued by the government on the 18th July, which has forced many to suspend production of TCM's as they are not compliant with the regulations.


http://eng.sfda.gov.cn/cmsweb/webportal/W43879541/A64028182.html


.

As quite a few posters have stated on advfn that you are a extreme danger
to even yourself PapelPower when it comes to posting misleading information.
Quite a few people who have attended todays Agm have posted on the thread
and one thing they all agree on is your attempts to distort the truth.

http://www.advfn.com/cmn/fbb/thread.php3?id=15076803

TFNF headline says it all :

30/07/08 08:32 TFNF Taihua says H1 Paclitaxel, Homoharringtonine sales ahead but value hit by forex



They are getting hit by RMB appreciation, and are unable to increase their US$ prices for exports. As was seen at last results, with the increases in overheads margins are falling.

This will accelerate the margins in falling, along with of course higher overheads yet again. Margins could be falling for some time.

They do not appear to have the cash for their planned expansion, and so is their going to be the use of debt ? or more equity issued ?

63.1m RMB budget generally means in China completion for about 80m RMB, so they are going to be short of around nearly 2m pounds after all their cash is used up, so they will go from being in the cash to being in debt.

Understand the move, they will need to protect margins going forward, and so the new plants are part of a plan to achieve this.


And then of course all the problems with PR........

If you want to make a summary you could as follows :

Overall margins were falling at the last results due to increased costs.

Costs are going to continue to increase, through wages rise pressure in China, increasing energy costs in China, increasing transportation costs.

Sales pricing levels are somewhat fixed in US$ terms (as from the AGM statement), which means on top of the rising costs and falling overall business margins, means actual margins on the products is going to fall too due to selling in US$ and not be able to account for the strength of the RMB against those set US$ prices, increasing pressure on the overall margins and making them fall more.

Problems with TCM's in China meaning production and/or marketing of certain types is "suspended" pending review.

Problems in Canada with stricter proposed government controls of TCM's, which may spread.

They are going to spend all their cash on new production facilities and likely go into debt to fund completion.

If and when they get EU/US approval they then still have to break into those markets against the already in place suppliers - that will mean much more marketing spend, likely lower margins, lots of up front costs, which may or may not translate into increased revenues 6 to 12 months after the attempt to break into the market.


One could therefore say, there is now lots of uncertainty ahead for TAIH, a potentially difficult phase is coming, and its likely why many people have been selling out.


All IMO, DYOR !!

Copy of a post by JTCod from the dark side..




JTCod - 20 Aug'08 - 10:34 - 5899 of 5901

Here's an interesting exercise and one where you can play around with the figures to suit your own assumtions.

Estimate for 2012:

Take EPS 3p based upon current exchange rate for 2007.

Split the 2007 revenue into 3 products (Pac, HH, TCM's) as per 2007 accounts to estimate the balance of profit for each product.
Revenue
47% HH
33% Paclitaxel
20% TCM’s

Then adjust TCM portion of profits up by +25% to accomodate superior margins and deduct from the other 2.
Should give Profits as a proportion of the 3p IRO:
44% HH,
31% Paclitaxel,
25% TCM's

Now you can project each one seperately:

HH
Until further approval's are granted on this drug in the US and EU allowing use for less chronic sufferers of leukemia, the management seem to be of the opinion that growing HH revenues will be easier if they deliver an injectable product. This seems a good strategy to me as even if the demand were there, not much more than 20kg could be produced pa even with a harvest of the whole region right now. If demand were increased, prices could rise quite rapidly. Though this is a double edged sword because suppliers of harvest would demand their share I am sure and of course have a captive market.

Injectable prices are something like 10x raw ingredient prices. So assuming 20kg ceiling (perhaps with the help of our own nursery in 5 years time) and delivered in injectable form, that should deliver something like 10x the raw ingrediant price. For prudence lets allow just 5x:

2007 profit 3p x 44% for 12kg + 66% to 20kg x 5 for injectable (discounted by 50%) = 11p (excluding any allowance for upward pressure on prices).


Paclitaxel:
This one is where the real action should happen because we are already well down the line with the EU application and the US should follow shortly after.

Paclitaxel sales are showing solid growth YOY and the company are yet to see the benfit from Korea, EU and US (approvals notwithstanding). If EU approval is forthcoming, I would expect the company to announce a plan to expand Paclitaxel production (already mentioned at in previous statements) by at least 3-400% (approx. 60-80kg pa). The reason being, we already have 50kg pa comfortable capacity (55-60kg at a pinch) so if they are proposing expansion at this stage when we only produce 20kg logic would say it must be beyond current capacity. The EU is a very large mature market after all. For these purposes though, lets assume the lower of those 2 figures.

Injectable prices are currently between 8-12x raw ingrediant prices. For prudence though, I have again allowed a 50% discount at just 5x the raw ingredient price we currently receive:

3p x 31% x 4 = 3.72p x 5 for injectables = 18.6p



TCM's
Grew 400% in 2005, 100% in 2006 and 29.6% in 2007.

Clearly this year has been disrupted and until we receive further guidance I wouldn't assume more than 10% growth this year for safety. However, with the Chinese government culling producers of TCM's across the country, I would anticipate upward pressure on growth and pricing for Taihua from 2009. Especially as the management have been so pro-active on developing large numbers of links with hospitals and clinics. Growth of TCM volume alone in China has been double figures over recent years without gaining market share and on top of this Taihua have launched new products and plan more over time. So for the following 4 years lets go with 25% annual growth. I don't think this assumption is beyond Taih. In all probability I think it could be too low.

With 25% of earnings in 2007, 3p (at current exchange rate) x 25% = 0.75p + 10% for 2008 + 25% for 2009/10/11/12 = 2p on a 5 year plan.

TOTAL: 31p
This would be equivalent to almost 1000% growth over 5 years. Which sounds fanciful until you check back and see Taihua have already achieved 1000% over the last 4 years.

My current 5yr earnings target is 25p though, as I have allowed for some dilution and + a little to cover unforeseen costs. I feel comfortable with that having already taken a hatchet to assumed injectable prices 5 years out. On top of that, I have made no allowance for the geared factor of revenue growth over that of fixed overheads. I could possibly be substantially out on the downside in this respect.

25p EPS would equate to 50% compound growth going forward and set that against a PE of less than 4x earnings right now, it would seem an attractive proposition.

25P on a PE of 12 would deliver a 26 bagger. (On 15x a 34 bagger)


Other possible value added opportunities:
One avenue open to Taihua once they establish an injectables plant should be 'outsourcing'. This could become a whole new earnings driver imo, whilst at the same time delivering economies of scale for Taihua's own injectable production. The overheads are so low in this company and their area in general that any big pharma looking to sell their own drugs into China would surely be tempted by such a proposition. Food for thought at least right now.

For Taih the above 5 year 'back of a fag packet' estimate is just a plan waiting to be put in motion imo. Though the injectables could be done anyway, the trigger should be when gain approval of the EU application. That's assuming they do gain approval which is of course not guaranteed.

Possibly some exciting times ahead though I think.

As ever all IMHO and of course DYOR

Dont forget to mention the dividend.

Nice to see this pile of **** exactly where it should be.

In case anyone wondered I have been enjoying a superb holiday and have been away from the net a lot, apart from the occasional post on III.

I refuse now to post on A DVFN, its has got terrible in terms of abusive rampers this year, totally pathetic and not worth anything now. The good thing is of course they are all now losing money, and I really hope some of those abusive idiots lose everything in the ongoing crash.

Some of us did warn back in January that it was best to sell anything and everything, and we were ridiculed by the abusive rampers, and now it comes to pass...........LOL :)

With what is going on, you can be sure that Asia will be into severe problems come 2nd half 2009, going into 2010.............not a time to be loaded up with "China" exposure stocks..........now people can see why everyone has been selling these "bargains" and not buying them.

The ultimate sign was China dropping interest rates, in the face of inflation, that was a real admission that they are now heading into severe problems :) ho ho ho.

Lots of Chinese Stock (rampers) trapped into this one I am told from all the postings there on the dark side (AFN BB's which are now ramper infested).

Does not look very interesting, margins falling, committed to expansion with falling margins, poor PR.

Tiddler, Chinese, Illiquid, Big Spread, AIM etc..

This one is about as unattractive as a normal stock could be made to look. Certainly not an investment, there are so many much better companies around, loads of this.

On top of the GNG admission that things are slowing down, today also saw ZTC (Chinese telecoms) say this which again is more evidence to say that things in China are under pressure, and those who said 2009 would be a bad year for anything China related, might well be proven correct :

"As has been widely reported, trading and credit conditions for SME's in the PRC have become increasingly difficult throughout the third quarter of 2008. This is due to deteriorating macro economic conditions outside the PRC and slowing economic growth and restrictive credit policies in China. As a consequence, our markets have become increasingly competitive, disruptive and oversupplied. ZTC has therefore achieved sales significantly below those seen in the same period last year.

As a consequence, the Company's working capital available to operate and expand its business has become constrained, as has been previously announced. The Company continues to review all aspects of its operations to reduce costs and improve efficiencies to improve the availability of working capital for new model and market development. The possible sale of assets referred to above is one example of a potential method of cash generation that is being actively considered."

From the recent TAIH update :

30th Sept 2008

http://www.investegate.co.uk/Article.aspx?id=200809301317376908E

"That production gap, combined with the effects of a strengthening Renminbi exchange rate on export sales, meant that although our sales of the anti-cancer active pharmaceutical ingredients, Paclitaxel and Homoharringtonine, remained strong, revenues for the half slipped by 11% to RMB 29.8 million, pulling pre-tax profits back to RMB 14.6 million from RMB 18.1 million for the same period a year earlier."


Those currency issues will be even worse now, look at the Chinese Yuan exchange rate since that update - how badly are export sales falling off now ?




The old saying, it can take years to gain a customer, and only seconds to lose one. How many are TAIH losing due to the currency issues ?

Bad update out.

I did warn and warn again over at AFN in the past that things were going to be bad, and currency movements will hurt sales for TAIH, but they were all abusive to me.

Now who has the last laugh..........serves them right.

i have always reckoned this share was crap too .... it's another kate barnes special, so no doubt she'll be posting shortly telling us all how marvellous the company really is and how it will come right in due course .... rather like TMC (which actually has a better chance)

cynic, yes, agreed.

I saw it coming for a long time, as you can read from my posts.

Must say I would love to read the AFN thread (but I do not go to the "dark side" now), all those numpties who were so sure the future was great and who were ramping like mad (like 8trader, Shaid1, Dorset64, yobstol and many others) they must have had a bit of a shock today to see their ramp crash and burn.

the minusculke volume also indicates that if you wanted to unload even a modest slab, it would either not be possible or MMs would murder you on the offer

Taihua will go to 1p.

nice interesting thread this, first time i have read it.
a lot of sensible and helpful comments from some posters and some not so sensible by others.
please read and decide for yourselves which are which.
regards
jkd

Someone asked me about "EU licenses" and isn't that going to change things for TAIH.

So in reply, I have said for a long time that it is my view that EU approval means exactly what it says, its approval to sell within the EU and nothing more.

However, all of their problems now (which is losing market sales to cheaper synthisised, and losing sales due to the Yuan strength) will be the same problems that stop them selling into the EU even after approval.

As an event itself EU approval means nothing in terms of revenue or profits, it simply opens another route to sell, it does not mean they can or will sell any significant volume.

So quite simply, the "rampers" of AFN have in the past tried to pick an event "EU approval" and ramp this as the "blue sky" event for TAIH.

Thats all the talk is, pure ramping as simply it opens a door, and given the rise of sythentics and the Yuan strength, I think its quite clear the existing doors are closing, let alone breaking into new sales area's (which needs big spending on marketing and promotion).

With Yuan strength still there, and with synthetics (the big competitor to natural TAIH products) riding a wave sales due to their lower cost and greater acceptance as just as effective.......the outlook for TAIH remains, IMV, very bad.

DYOR !

You get the feeling this pile of "ex-ramped" poo (imo) is heading for say 3p levels ?

Very undervalued and screaming buy

Its totally overvalued and a sceaming sell ??????? ;) LOL

What is the Value of net assets per share?

bugger all on a good day i would venture

15.67p

so buy all you can, though i wonder who vaklued the assets ..... anyway, i bet you could pick up lots of stock for <12.5p with the sellers delighted to have the shares taken off their hands

LOL @ cynic.

Very true.

Any net asset value is historic, gawd only knows that they have purchased and spent in the meantime. The only way to see the real value of the net assets is a valuation with results, however, TAIHUA appear to put results out 6 months after the end of the financial year, so even those figures are 6 months out of date.

In simple terms, you have no idea what is going on, and so, the SP is where it is, as their trading update was awful and their outlook very similar IMO.

LOL

Up 77% today?

with a factual spread of 7.00/8.50 why would you want to touch this even with someone else's!

cynic never one for you but some are curious when a sleeper goes up 77%.

i was curious too ..... "Curious Yellow" comes to mind!

agree, joke spread, needs to jump about 30% just to profit!!

E U approval confirmed on 24 Sept, this is now going to fly.

DYOR.

sp sudden jump?

Sp up 35%!

I love it, results due by end of month along with the news that we've been waiting for, for ages.

Up 43%, just wait until everyone else finds out. This rise is on the back of current investors stumbling upon EU accreditaion before it being released by the company. Also the market were caught short initially by the surge in buying.

Good luck all, I'm in and staying for the foreseeable future.

News out officially in a rushed RNS timed 11:01, sp still rising.

LOL

Now a 66% gain on the day. Never mind PP, why not trade the rise then.

TIDMTAIH

RNS Number : 7499Z
Taihua Plc
28 September 2009





Taihua plc
("Taihua" or the "Company")


Application Update


Taihua confirms that the European Directorate for the Quality of Medicines has
granted Taihua a certificate of suitability for paclitaxel.
Further information will be provided in due course.


+------------------------------------+------------------------------------+
| Nicholas Lyth, Chairman, Taihua | 0776 990 6686 |
| plc | |
+------------------------------------+------------------------------------+
| Katy Mitchell, WH Ireland Limited | +44 161 832 2174 |
+------------------------------------+------------------------------------+











This information is provided by RNS
The company news service from the London Stock Exchange
END

Sorry now 83%, I cant keep up.

By the way I'm not ramping but merely stating facts as they happen.

Oily, did. Time to offload now.

Cannot get any real volume so its get out quick time now.

up 108% and top of the leader board.

Cheers PP good luck.

Timed that top to perfection :)

All out.

EU approval means nothing, but a nice spike to trade. They are struggling to sell in Asia so have no chance of selling in Europe IMO. Never mind, nice spike :)

Hope people managed to get out, before getting trapped in.

As usual, awful results and a massive move down.

Well done anyone who got the spike and sold at the top, unlucky for anyone still in.

Looks ok now again, just had some dummy tests and there seems to be
very little stock around, sell 150k at a premium buy 2.5k close to full offer.

Swimming against the tide but ready to break out if good news hits about
a european partner will be a big boost, the company is still supported by
a large amount of cash next to their market cap.

Totally expected (if you are sensible and not a ramper)

Anyone thinking different was living on the moon. Remains a large avoid IMO.


RNS Number : 8919G
Taihua Plc
09 February 2010

TAIHUA PLC
("Taihua" or "the Company")

TRADING UPDATE

Taihua plc a China-based pharmaceutical company which manufactures Paclitaxel,
Homoharringtonine and Traditional Chinese Medicines ("TCM") would like to update
its shareholders on its progress in 2009 before the release of its financial
results for the 12 months ended 31 December 2009.

Overview

As disclosed in the AGM Statement of 24 July 2009 and the 2009 interim results
of the Company, the first half of 2009 was very difficult for the business of
Taihua. Impacted by the global financial crisis and foreign exchange rate
fluctuations, the sales volume of Paclitaxel and Homoharringtonine, the
Company's principal products, had decreased when compared to the same period in
2008.

The Company's customers' demands increased in the second half of 2009 compared
to the first half of 2009 (Paclitaxel sales in H1: 4750 grams; Pacliataxel sales
in H2: 6805 grams (an increase of 43.26%) and homoharringtonine sales in H1:
1620 grams and homoharringtonine sales in H2: 3570 grams (an increase of 120%)).
However, the increase was not sufficient to arrest the decline in year end
profits compared with the previous year.

Therefore, although the trading performance of the Company has improved in the
second half of 2009, the sales volume of Paclitaxel and homoharringtonine in
2009, as affected by the poor performance in the first half of 2009, was still
lower than that in 2008.

Paclitaxel and Homoharringtonine

The prices of Paclitaxel and Homoharringtonine remained unchanged in the second
half of 2009.

During 2009, the Company sold 11,555 grams of Paclitaxel, a decrease of 31%
compared to 2008, and 5,190 grams of Homoharringtonine, a decrease of 43%
compared to 2008.

TCM products

The Company has not fully recovered from the adverse influence of the suspension
of TCM production in 2008. As a result, the sales revenue of TCM products in
2009 decreased by 9% compared to 2008.

Outlook

The Company is now concentrating on further discussions with potential European
distributors and expects to conclude the negotiations with potential European
distributors in March 2010.

Proselenes - 09 Feb 2010 12:53 - 337 of 337
Totally expected (if you are sensible and not a ramper)


That rules you out then PP :-))

ps nothing too bad with that statement, mm's fishing for some cheaper stock !

In this market nothing but a brilliant TS will get prices up so nothing to be too worried about, company is backed by a lot of cash and will rally when it signs
up their European partner.

ravey davy gravy - 09 Feb 2010 13:20 - 339 of 339

ps nothing too bad with that statement, mm's fishing for some cheaper stock !

ERRRRRR MM"S DO NOT FISH FOR CHEAPER STOCK ON AWFUL NEWS. THATS A DESPERATE LINE TO COME OUT WITH.

In this market nothing but a brilliant TS will get prices up so nothing to be too worried about, company is backed by a lot of cash and will rally when it signs
up their European partner.

A EUROPEAN DISTRIBUTER AGREEMENT IS GOING, IN ITSELF, TO DO NOTHING. THEY HAVE TO SELL THE PRODUCT, ALL IT DOES IS OPEN POTENTIAL, BUT THERE IS NO CERTAINTY THEY CAN SELL.

DO NOT FORGET THEY ARE LOSING THEIR EXPORT MARKET IN ASIA NOW AS THEY ARE TOO EXPENSIVE WITH THE YUAN GETTING STRONG, AND SO THE SAME PRICING PRESSURE EXISTS IN EUROPE AGAINST OTHER SUPPLIERS.

THE OUTLOOK IS BLEAK.

Dont you get bored with a never ending vendetta on a company Papel Power ?

Life is too short, you've been talking down this company for so many years others
just ignore you now, does CAPS LOCKED make me want to take you more seriously
...erm no...surely you have better things to do than wish for a company to go bust !

Simple bit of mm fishing, they flushed out a few panic sellers but once they dried up the price is back up and away and once again there is little stock about to buy.

I've enjoyed this one falling down from 25p to 5p and below.

Its still a bag of poo, illiquid little small cap with problems as they export a lot and the Yuan is now too strong, so they are hurting.

If you want to buy Chinese companies avoid software, and also avoid ones who rely on exports like Taihua do.....uncompetitive.

Focus on the "domestic demand" ones......like WCC.

you and i certainly agree on this load of laxative!

Yep, this certainly is one crap stock.

Todays price just shows how much people take note of you Papel Papel, your deramping of this is more a vendetta than fundamentals hence everybody ignores you thesedays.

why must someone who has a dislike for a certain stock, and posts to that effect be perjoratively termed a deramper? ...... that being so, what does that make you?

Because the company is still profitable and has no debt with a large cash balance.

If the company was loss making and in debt then maybe PP would have a case.

And i dont have a position so my thoughts are unbiased, i recall a similar style vendetta with WCC and then he buys and starts to ramp it, maybe that is what
PP wants to do here ?

you didn't answer the question

Dont waste your time with me again cynic, you should get yourself over to advfn where i'm sure you will get the attention you crave.

cynic, ignore the rampers.

Most are trapped in from 20p + levels and are total dreamers.

The company openly admits its in trouble as the Yuan is so strong that its not competitive in Asia anymore and its Asia market sales have collapsed and in order to keep selling margins have fallen ?

European deal means nothing, unless the can sell and show they can sell, and given other suppliers are getting all the market share in Asia, well, what do you expect to happen in Europe...... ?

i wouldn't touch this share with RDD's!
i seem to remember one of the coven telling us all how wonderful this share was too, somewhere in the not so distant past

MR C. !!! Am not stalking you but what are you doing EVEN doing on this thread. Bit like catching a scoutmaster in a brothel . lts a complete DUD !!!!

et tu Brute!

but as you know the elements are mixed in me . All the rest acted in envy. l alone for the common good. So much apparently that nature may stand up and say this was a man . .. How behave and go back to an oilie thread ...

i'm actually trying very hard to diversify my portfolio away from oilies and miners, but at the moment, both those sectors still look best options, with one or two odd exceptions ..... quite fancy buying a few Google, but shall have to get logged into US stocks at IG

Water perhaps ( catch while trading well below 180 day average) and they pay nice dividends .UU is my pick there - has never let me down .,,,,,,,or electronics sector. Trouble with latter is that so many products are outdated before they reach the marketplace eg Broadband . ...lnteresting bit of trivia . someone worked out that if automotive sector made the same progress as the electronics sector they would have to produce a car that achieved 1600 miles to the gallon .

try CSR

on face value fundementals appear ok. Chart set to 10,30 , 100 and 180 ema suggest its heading north but cant see that much upside- a bit expensive for me personally...the 180 ema is 406 which would stress me a little But.ld have to properly look into it before giving anything approaching objectivity

go to CSR thread

I believe this is about to wake up!! Too cheap now.

why? ...... basically the company's a load of rotting bones and weeds

Do they sell herbal Viagra ?

Their cash in the Bank is worth 11.5p per share and 16.5p with the asset's...a major holder/seller was bought out on Friday by a long term holder....maybe not so crap and could start to move forward with the sp.

Good deal signed up this week as well.



Taihua Plc Distribution Agreement RNS Number : 2500WTaihua Plc16 November 2010 

Taihua plc

("Taihua" or the "Company")

Distribution Agreement

Taihua is pleased to announce that, on 12 November 2010, Taihua Natural Plant Pharmaceutical Co. Ltd. ("TNP") appointed Xi'an Zaolutang Pharmaceutical Group Co., Ltd. ("Zaolutang") as its sole distributor in respect of the distribution in China of Biantong Pian, a new Traditional Chinese Medicine ("TCM") product which the Company commenced marketing in October 2010, and entered into an exclusive distribution agreement ("Distribution Agreement") with Zaolutang.

Pursuant to the terms and conditions of the Distribution Agreement, Zaolutang undertakes to distribute 330,000 boxes of Biantong Pian with a total value of RMB10.395 million in the first year and its target will be increased by 20% in the second year. Zaolutang has agreed to pay a deposit of RMB500,000 to TNP. If Zaolutang fails to achieve 60% of the target in the first year or fails to achieve 80% of the targets for two consecutive years, TNP is entitled to terminate the Distribution Agreement and the deposit will be forfeited.

Commenting on this agreement, Nicholas Lyth, Non-Executive Chairman said:

"Traditional Chinese Medicines is a sector in which Taihua has considerable expertise. I am pleased that Zaolutang, a well respected TCM distributor, has recognised this. In the first 6 months of 2010 our TCM sales were RMB2.124m so on-target sales of Biantong Pian will dramatically change the scale of our TCM revenues. With a strong balance sheet the Board continues to look for opportunities to complement our current TCM range."

Moving upwards.

anybody know why alll of a sudden there is activity in this stock?

House Brokers note out 2 days ago

In hindsight I find post 367 rather funny, no offence intended.

Four and a half years of silence have ensued after this post.